Q2 FY26 · Ended Jun 30, 2026 · View SEC filing
Most of the revenue is drug spend passing through
Pharmacy is 79.8% of revenue, but nearly all of it goes back out, so contract terms set profit, not sales.
For investorsWhat Evernorth's earnings depend on as contracts are reset
For foundersRunning a thin-spread business at enormous scale
Evernorth books 85.8% of revenue, yet the filing credits Cigna Healthcare, the medical plans, with the quarter's profit gain.
Overhead rose 1.08% while revenue rose 6.68%, and on a margin this thin that gap lifts operating income sharply.
Net income rose 14.89%, but minority owners' share more than doubled, so shareholders' net income rose only 8.36%.
Unlock the financial breakdown, competitive insights, historical trends and founder playbook, plus research across the company library.
Free CXProWealth membership required
Business Lens describes Cigna from its own filings with the SEC. It is not a view on its shares, a target, or advice to buy, sell or hold anything; figures are as filed and may be restated by the company later. The filing is linked above.
